Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MultiPlan Reports First Quarter 2022 Results

MPLN

Q1 2022 Revenues of $298.0 million, Net Income of $44.0 million, and Adjusted EBITDA of $225.4 million

Growth in revenues of 16.9% over Q1 2021, driven by an increase in identified potential medical cost savings to approximately $5.6 billion in Q1 2022

MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the first quarter ended March 31, 2022.

“MultiPlan delivered very strong results, exceeding our expectations on revenue and Adjusted EBITDA for the first quarter 2022. Our results continue to demonstrate the strength and recurring nature of our business model and the unique value MultiPlan provides to all stakeholders in a complex U.S. healthcare system,” said Dale White, CEO of MultiPlan. “To accomplish this while implementing the No Surprises Act on behalf of customers speaks to our platform’s scale and our speed and flexibility in customizing solutions that meet our customers’ needs. Our relentless focus on operational excellence continues to underpin our industry-leading position with our payor customers, and I remain confident that MultiPlan is well-positioned to deliver strong results in 2022 and beyond.”

The Company remains focused on its mission of delivering fairness, efficiency and affordability to the U.S. healthcare system and on driving sustained long-term growth by enhancing its product offerings to payors, extending into new payor customer segments, and expanding its platform to serve MultiPlan’s 1.2 million providers, its more than 700 payor customers, and 60 plus million consumers.

Business and Financial Highlights

  • Revenues of $298.0 million for Q1 2022, an increase of 16.9% over Q1 2021 revenues of $254.9 million.
  • Net income of $44.0 million for Q1 2022, a decrease of 4.1% from Q1 2021 net income of $45.9 million.
  • Adjusted EBITDA of $225.4 million for Q1 2022, an increase of 17.9% over Q1 2021 Adjusted EBITDA of $191.1 million.
  • Net Cash provided by operating activities of $194.9 million for Q1 2022, compared to $170.9 million for Q1 2021.
  • Free Cash Flow of $170.5 million for Q1 2022, compared to $152.8 million for Q1 2021.
  • The Company processed approximately $31.7 billion in claim charges during the first quarter of 2022, identifying potential medical cost savings of approximately $5.6 billion.

The first quarter 2022 results reflect an estimated COVID-related revenue impact of $3-5 million and an estimated COVID-related Adjusted EBITDA impact of $2-4 million, as compared to an estimated COVID-related revenue impact of $18-22 million and an estimated COVID-related Adjusted EBITDA impact of $16-18 million in Q1 2021.

2022 Financial Guidance

The Company is maintaining its Full Year 2022 guidance, detailed in the table below:

Financial Metric

FY 2022 Guidance

Revenues

$1,160 million to $1,200 million

Adjusted. EBITDA

$850 million to $875 million

Cash flow from operations

$380 million to $420 million

Capital expenditures

$90 million to $100 million

Interest expense

$280 million to $290 million

Depreciation

$65 million to $70 million

Amortization of intangible assets

$335 million to $345 million

Effective tax rate

25% to 28%

The Company is updating the estimated COVID impact in its annual guidance to assume an estimated COVID-related revenue impact of approximately $15-20 million, which compares with a prior estimate of $25-30 million, and an estimated COVID-related Adjusted EBITDA impact of approximately $12-16 million, which compares with a prior estimate of $20-24 million.

The Company anticipates Q2 2022 revenues between $285 million and $295 million and Adjusted EBITDA between $205 million and $215 million.

Conference Call Information

The Company will host a conference call today, Tuesday, May 10, 2022 at 8:00 a.m. U.S. Eastern Daylight Time (ET) to discuss its financial results. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration may be completed at any time up to and following the call start time.

To pre-register, go to: https://www.incommglobalevents.com/registration/q4inc/10671/multiplan-corporation-first-quarter-2022-earnings-conference-call/

A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.multiplan.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck will also be available on this section of the Company’s website.

For those unable to listen to the live conference call, a replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company’s website or by dialing (866) 813-9403 or (929) 458-6194. The replay access code is 996246.

About MultiPlan

MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment and revenue integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government and property and casualty markets. For more information, visit it www.multiplan.com.

Forward Looking Statements

This press release includes statements that express our and our subsidiaries’ opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements”. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “forecasts,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this press release, including the discussion of 2022 outlook, guidance and the impact of The No Surprises Act and COVID-19, and these forward-looking statements reflect management’s expectations regarding our future growth, results of operations, operational and financial performance and business prospects and opportunities. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting the business. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual financial results, including: the impact from the COVID-19 pandemic and its related effects on our projected results of operations, financial performance or other financial metrics; loss of our customers, particularly our largest customers; decreases in our existing market share or the size of our Preferred Provider Organization networks; effects of competition; effects of pricing pressure; the inability of our customers to pay for our services; decreases in discounts from providers; the loss of our existing relationships with providers; the loss of key members of our management team; pressure to limit access to preferred provider networks; the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected; our ability to identify, complete and successfully integrate acquisitions; changes in our industry; interruptions or security breaches of our information technology systems and other cyber security attacks; our ability to protect proprietary applications; our inability to expand our network infrastructure; our ability to maintain effective internal controls over financial reporting; our ability to continue to attract, motivate and retain a large number of skilled employees, and adapt to the effects of inflationary pressure on wages; changes in our regulatory environment, including healthcare law and regulations; the expansion of privacy and security laws; heightened enforcement activity by government agencies; our ability to pay interest and principal on our notes and other indebtedness; the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors; other factors disclosed in our Securities and Exchange Commission (“SEC”) filings; and other factors beyond our control.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, including those under “Risk Factors” therein, and other documents filed or to be filed with the SEC by us. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), this press release contains certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and Adjusted cash conversion ratio. A non-GAAP financial measure is generally defined as a numerical measure of a company’s financial or operating performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP.

EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and Adjusted cash conversion ratio are supplemental measures of MultiPlan’s performance that are not required by or presented in accordance with GAAP. These measures are not measurements of our financial or operating performance under GAAP, have limitations as analytical tools and should not be considered in isolation or as an alternative to net income (loss), cash flows or any other measures of performance prepared in accordance with GAAP.

EBITDA represents net income before interest expense, interest income, income tax provision, depreciation, amortization of intangible assets, and non-income taxes. Adjusted EBITDA is EBITDA as further adjusted by certain items as described in the table below.

In addition, in evaluating EBITDA and Adjusted EBITDA you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of EBITDA and Adjusted EBITDA. The presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. The calculations of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Based on our industry and debt financing experience, we believe that EBITDA and Adjusted EBITDA are customarily used by investors, analysts and other interested parties to provide useful information regarding a company’s ability to service and/or incur indebtedness.

We also believe that Adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Both EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider either in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of the limitations are:

  • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;
  • EBITDA and Adjusted EBITDA do not reflect interest expense, or the cash requirements necessary to service interest or principal payments on our debt;
  • EBITDA and Adjusted EBITDA do not reflect our tax expense or the cash requirements to pay our taxes; and
  • Although depreciation and amortization are non-cash charges, the tangible assets being depreciated will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements.

​MultiPlan’s presentation of Adjusted EBITDA should not be construed as an inference that our future results and financial position will be unaffected by unusual items.

Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, all as disclosed in the Statements of Cash Flows. Unlevered Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, plus cash interest paid, all as disclosed in the Statements of Cash Flows. Free Cash Flow and Unlevered Free Cash Flow are measures of our operational performance used by management to evaluate our business after purchases of property and equipment and, in the case of Unlevered Free Cash Flow, prior to the impact of our capital structure. Free Cash Flow and Unlevered Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, MultiPlan’s definitions of Free Cash Flow and Unlevered Free Cash Flow are limited, in that they do not represent residual cash flows available for discretionary expenditures, due to the fact that the measures do not deduct the payments required for debt service, in the case of Unlevered Free Cash Flow, and other contractual obligations or payments made for business acquisitions.

Adjusted cash conversion ratio is defined as Unlevered Free Cash Flow divided by Adjusted EBITDA. MultiPlan believes that the presentation of the Adjusted cash conversion ratio provides useful information to investors because it is a financial performance measure that shows how much of its Adjusted EBITDA MultiPlan converts into Unlevered Free Cash Flow.

We have not reconciled the forward-looking Adjusted EBITDA guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses (including expenses relating to the business combination), certain fair value measurements and costs related to the uncertainties caused by the global COVID-19 pandemic, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

MULTIPLAN CORPORATION

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

March 31,
2022

December 31,
2021

Assets

Current assets:

Cash and cash equivalents

$

350,830

$

185,328

Restricted cash

2,958

3,051

Trade accounts receivable, net

78,206

99,905

Prepaid expenses

21,872

24,910

Prepaid taxes

5,064

Other current assets, net

909

999

Total current assets

454,775

319,257

Property and equipment, net

221,047

213,238

Operating lease right-of-use assets

27,715

30,104

Goodwill

4,363,121

4,363,070

Other intangibles, net

3,199,883

3,285,037

Other assets

9,227

9,701

Total assets

$

8,275,768

$

8,220,407

Liabilities and Shareholders’ Equity

Current liabilities:

Accounts payable

$

10,939

$

13,005

Accrued interest

78,147

55,685

Accrued taxes

41,983

Operating lease obligation, short-term

7,219

6,883

Current portion of long-term debt

13,250

13,250

Accrued compensation

24,558

25,419

Other accrued expenses

25,872

27,666

Total current liabilities

201,968

141,908

Long-term debt

4,878,386

4,879,144

Operating lease obligation, long-term

24,037

26,725

Private Placement Warrants and unvested founder shares

61,259

74,000

Deferred income taxes

718,533

753,825

Other liabilities

109

135

Total liabilities

5,884,292

5,875,737

Commitments and contingencies (Note 5)

Shareholders’ equity:

Shareholder interests

Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued

Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 666,045,694 and 665,456,180 issued; 638,928,288 and 638,338,774 shares outstanding

67

67

Additional paid-in capital

2,314,488

2,311,660

Retained earnings

269,090

225,112

Treasury stock — 27,117,406 and 27,117,406 shares

(192,169

)

(192,169

)

Total shareholders’ equity

2,391,476

2,344,670

Total liabilities and shareholders’ equity

$

8,275,768

$

8,220,407

MULTIPLAN CORPORATION

Unaudited Condensed Consolidated Statements of Income and Comprehensive Income

(in thousands, except share and per share data)

Three Months Ended March 31,

2022

2021

Revenues

$

298,046

$

254,864

Costs of services (exclusive of depreciation and amortization of intangible assets shown below)

47,072

39,730

General and administrative expenses

32,588

31,996

Depreciation

16,596

16,165

Amortization of intangible assets

85,154

84,708

Total expenses

181,410

172,599

Operating income

116,636

82,265

Interest expense

71,445

63,717

Interest income

(12

)

(4

)

Gain on investments

(289

)

Change in fair value of Private Placement Warrants and unvested founder shares

(12,741

)

(40,375

)

Net income before taxes

58,233

58,927

Provision for income taxes

14,255

13,050

Net income

$

43,978

$

45,877

Weighted average shares outstanding – Basic

638,497,587

655,113,523

Weighted average shares outstanding – Diluted

639,015,094

655,113,653

Net income per share – Basic

$

0.07

$

0.07

Net income per share – Diluted

$

0.07

$

0.07

Comprehensive income

$

43,978

$

45,877

MULTIPLAN CORPORATION

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

Three Months Ended March 31,

2022

2021

Operating activities:

Net income

$

43,978

$

45,877

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

16,596

16,165

Amortization of intangible assets

85,154

84,708

Amortization of the right-of-use asset

1,683

1,779

Stock-based compensation

3,130

968

Deferred income taxes

(35,343

)

(47,049

)

Non-cash interest costs

2,577

2,884

Gain on equity investments

(289

)

Loss on disposal of property and equipment

49

630

Change in fair value of Private Placement Warrants and unvested founder shares

(12,741

)

(40,375

)

Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:

Accounts receivable, net

21,699

11,960

Prepaid expenses and other assets

3,602

(3,555

)

Prepaid taxes

5,064

Operating lease obligation

(1,646

)

(150

)

Accounts payable and accrued expenses and other

61,424

97,065

Net cash provided by operating activities

194,937

170,907

Investing activities:

Purchases of property and equipment

(24,454

)

(18,113

)

Proceeds from sale of investment

289

5,616

HST Acquisition, net of cash acquired

(28

)

DHP Acquisition, net of cash acquired

(149,873

)

Net cash used in investing activities

(24,165

)

(162,398

)

Financing activities:

Repayments of Term Loan B

(3,313

)

Taxes paid on settlement of vested share awards

(1,957

)

(264

)

Borrowings on finance leases, net

32

Net cash used in financing activities

(5,270

)

(232

)

Net increase in cash and cash equivalents

165,502

8,277

Cash and cash equivalents at beginning of period

185,328

126,755

Cash and cash equivalents at end of period

$

350,830

$

135,032

Cash and cash equivalents

$

350,830

$

135,032

Restricted cash

2,958

Cash, cash equivalents and restricted cash at end of period

$

353,788

$

135,032

Noncash investing and financing activities:

Purchases of property and equipment not yet paid

$

4,918

$

5,056

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

$

40

$

Supplemental disclosure of cash flow information:

Cash paid during the period for:

Interest

$

(46,197

)

$

(22,279

)

Income taxes, net of refunds

$

(2,833

)

$

(3,000

)

MULTIPLAN CORPORATION

Calculation of EBITDA and Adjusted EBITDA

(in thousands)

Three Months Ended March 31,

2022

2021

Net income

$

43,978

$

45,877

Adjustments:

Interest expense

71,445

63,717

Interest income

(12

)

(4

)

Income tax provision

14,255

13,050

Depreciation

16,596

16,165

Amortization of intangible assets

85,154

84,708

Non-income taxes

553

513

EBITDA

$

231,969

$

224,026

Adjustments:

Other (income) expenses

(890

)

658

Integration expenses

1,672

559

Change in fair value of Private Placement Warrants and unvested founder shares

(12,741

)

(40,375

)

Transaction-related expenses

2,555

5,225

Gain on investments

(289

)

Stock-based compensation

3,130

968

Adjusted EBITDA

$

225,406

$

191,061

Calculation of Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio

(in thousands)

Three Months Ended March 31,

2022

2021

Net cash provided by operating activities

$

194,937

$

170,907

Purchases of property and equipment

(24,454

)

(18,113

)

Free Cash Flow

170,483

152,794

Interest paid

46,197

22,279

Unlevered Free Cash Flow

$

216,680

$

175,073

Adjusted EBITDA

$

225,406

$

191,061

Adjusted Cash Conversion Ratio

96

%

92

%

Net cash used in investing activities

$

(24,165

)

$

(162,398

)

Net cash used in financing activities

$

(5,270

)

$

(232

)

Tags: